• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉搭桥术与药物洗脱支架植入术:冠心病患者在头三年内再次干预、转为需要重症护理、入住养老院及死亡的概率:基于德国健康保险数据的评估

Coronary artery bypass grafting drug-eluting stent implantation: the probabilities of reintervention, transition to severe care-need, nursing home, and death in patients with coronary artery disease within the first three years: evaluations based on health claims data in Germany.

作者信息

Georges Daniela, Kreft Daniel, Doblhammer Gabriele

机构信息

Department of Sociology and Demography, University of Rostock, Rostock, Germany.

German Centre for Neurodegenerative Diseases, Bonn, Germany.

出版信息

J Thorac Dis. 2024 Aug 31;16(8):4863-4874. doi: 10.21037/jtd-24-251. Epub 2024 Aug 16.

DOI:10.21037/jtd-24-251
PMID:39268109
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11388224/
Abstract

BACKGROUND

Coronary artery bypass grafting (CABG) and drug-eluting stent implantation (DES) are established as central methods of revascularization for patients with coronary artery disease. This study aims to analyse the health trajectories of patients after first CABG or first, second or third DES within the first three years, with a focus on follow-up interventions, severe care need, transition into a nursing home, and death.

METHODS

Based on health claims data (n=11,581), we estimated age-and sex standardized probabilities of reintervention, and of transition to severe care need, nursing home and death following initial CABG (n=2,008) or DES (n=9,573) for patients aged 50 years and older using logistic regression models and direct standardization. Up to three follow-up DES interventions and one follow-up CABG were considered.

RESULTS

There was a fairly high probability of reintervention, particularly after a DES and within the first year. Follow-up interventions were more likely to involve DES than CABG. The probability of death was notably higher for CABG patients. The probabilities of severe care need and moving to a nursing home were slightly lower and similar across the revascularization methods and over time.

CONCLUSIONS

DES and CABG are often associated with a need for follow-up interventions. Depending on the procedure, however, the risk of repeat surgery or adverse health outcomes varies. DES is associated with a relatively high probability of follow-up revascularization and a nearly constant probability of negative health outcomes in the short and medium term. In contrast, within three years after a CABG, follow-up reinterventions are rather rare. However, this procedure is particularly associated with an increased risk of mortality and short-term transition into a nursing home.

摘要

背景

冠状动脉旁路移植术(CABG)和药物洗脱支架植入术(DES)已成为冠心病患者血运重建的主要方法。本研究旨在分析首次接受CABG或首次、第二次或第三次DES治疗的患者在头三年内的健康轨迹,重点关注随访干预、重症护理需求、转入养老院以及死亡情况。

方法

基于健康保险数据(n = 11,581),我们使用逻辑回归模型和直接标准化方法,估计了50岁及以上患者在首次接受CABG(n = 2,008)或DES(n = 9,573)后再次干预、转为需要重症护理、入住养老院和死亡的年龄和性别标准化概率。考虑了多达三次随访DES干预和一次随访CABG。

结果

再次干预的可能性相当高,尤其是在DES治疗后且在第一年内。随访干预更有可能涉及DES而非CABG。CABG患者的死亡概率明显更高。重症护理需求和入住养老院的概率略低,且在不同血运重建方法和不同时间内相似。

结论

DES和CABG通常都需要进行随访干预。然而,根据手术方式不同,再次手术或不良健康结局的风险也有所不同。DES与随访血运重建的相对高概率以及短期和中期负面健康结局的近乎恒定概率相关。相比之下,CABG术后三年内随访再次干预相当罕见。然而,该手术特别与死亡率增加和短期内转入养老院的风险相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bbf/11388224/fcb23874ff62/jtd-16-08-4863-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bbf/11388224/00f5de939869/jtd-16-08-4863-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bbf/11388224/fcb23874ff62/jtd-16-08-4863-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bbf/11388224/00f5de939869/jtd-16-08-4863-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bbf/11388224/fcb23874ff62/jtd-16-08-4863-f2.jpg

相似文献

1
Coronary artery bypass grafting drug-eluting stent implantation: the probabilities of reintervention, transition to severe care-need, nursing home, and death in patients with coronary artery disease within the first three years: evaluations based on health claims data in Germany.冠状动脉搭桥术与药物洗脱支架植入术:冠心病患者在头三年内再次干预、转为需要重症护理、入住养老院及死亡的概率:基于德国健康保险数据的评估
J Thorac Dis. 2024 Aug 31;16(8):4863-4874. doi: 10.21037/jtd-24-251. Epub 2024 Aug 16.
2
Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.冠状动脉旁路移植术与药物洗脱支架置入术治疗左主干或多支冠状动脉疾病:一项个体患者数据的荟萃分析。
JACC Cardiovasc Interv. 2016 Dec 26;9(24):2481-2489. doi: 10.1016/j.jcin.2016.10.008.
3
[Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].[经皮冠状动脉介入治疗或冠状动脉旁路移植术治疗无保护左主干冠状动脉分叉病变的长期预后比较]
Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Jan 25;45(1):19-25. doi: 10.3760/cma.j.issn.0253-3758.2017.01.005.
4
Revascularization in severe left ventricular dysfunction: outcome comparison of drug-eluting stent implantation versus coronary artery by-pass grafting.严重左心室功能不全的血运重建:药物洗脱支架植入与冠状动脉旁路移植术的疗效比较
Catheter Cardiovasc Interv. 2007 Jul 1;70(1):26-33. doi: 10.1002/ccd.21072.
5
A comparison of drug-eluting stent and coronary artery bypass grafting in mildly to moderately ischemic heart failure.药物洗脱支架与冠状动脉旁路移植术治疗轻中度缺血性心力衰竭的比较。
ESC Heart Fail. 2022 Jun;9(3):1749-1755. doi: 10.1002/ehf2.13852. Epub 2022 Feb 22.
6
Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.冠状动脉旁路移植术与经皮冠状动脉介入治疗对三血管病变患者的比较:SYNTAX 试验的最终五年随访结果。
Eur Heart J. 2014 Oct 21;35(40):2821-30. doi: 10.1093/eurheartj/ehu213. Epub 2014 May 21.
7
Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents in patients with multivessel coronary artery disease compared to coronary artery bypass surgery five-years after intervention.与冠状动脉搭桥手术相比,药物洗脱支架经皮冠状动脉介入治疗多支冠状动脉疾病患者术后五年的成本效益。
Catheter Cardiovasc Interv. 2014 Dec 1;84(7):1029-39. doi: 10.1002/ccd.25397. Epub 2014 Feb 1.
8
Comparison of Coronary Artery Bypass Grafting and Drug-Eluting Stent Implantation in Patients With Chronic Kidney Disease: A Propensity Score Matching Study.慢性肾脏病患者冠状动脉旁路移植术与药物洗脱支架植入术的比较:一项倾向评分匹配研究
Front Cardiovasc Med. 2022 Apr 1;9:802181. doi: 10.3389/fcvm.2022.802181. eCollection 2022.
9
5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience.药物洗脱支架置入与冠状动脉旁路移植术治疗无保护左主干病变的 5 年结果:米兰经验。
JACC Cardiovasc Interv. 2010 Jun;3(6):595-601. doi: 10.1016/j.jcin.2010.03.014.
10
CABG Versus PCI: Greater Benefit in Long-Term Outcomes With Multiple Arterial Bypass Grafting.冠状动脉搭桥术与经皮冠状动脉介入治疗:多支动脉搭桥术在长期预后方面具有更大益处。
J Am Coll Cardiol. 2015 Sep 29;66(13):1417-27. doi: 10.1016/j.jacc.2015.07.060.

引用本文的文献

1
Retraction: Coronary artery bypass grafting drug-eluting stent implantation: the probabilities of reintervention, transition to severe care-need, nursing home, and death in patients with coronary artery disease within the first three years: evaluations based on health claims data in Germany.撤稿声明:冠状动脉旁路移植术与药物洗脱支架植入术:冠心病患者在头三年内再次干预、转为需要重症护理、入住疗养院及死亡的概率:基于德国健康保险数据的评估
J Thorac Dis. 2025 Jan 24;17(1):522-523. doi: 10.21037/jtd-2024-04. Epub 2025 Jan 22.

本文引用的文献

1
PCI or CABG for left main coronary artery disease: the SWEDEHEART registry.经皮冠状动脉介入治疗或冠状动脉旁路移植术治疗左主干冠状动脉疾病:SWEDEHEART 注册研究。
Eur Heart J. 2023 Aug 7;44(30):2833-2842. doi: 10.1093/eurheartj/ehad369.
2
Long term outcomes of percutaneous coronary intervention vs coronary artery bypass grafting in patients with diabetes mellitus with multi vessels diseases: A meta-analysis.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗多支血管病变糖尿病患者的长期疗效:一项荟萃分析。
Int J Cardiol Heart Vasc. 2023 Feb 26;46:101185. doi: 10.1016/j.ijcha.2023.101185. eCollection 2023 Jun.
3
Long-Term Outcomes Comparison Between Surgical and Percutaneous Coronary Revascularization in Patients With Multivessel Coronary Disease or Left Main Disease: A Systematic Review and Study Level Meta-Analysis of Randomized Trials.
多支血管病变或左主干病变患者冠状动脉旁路移植术与经皮冠状动脉介入治疗的长期结局比较:随机试验的系统评价和研究水平荟萃分析。
Curr Probl Cardiol. 2023 Jul;48(7):101699. doi: 10.1016/j.cpcardiol.2023.101699. Epub 2023 Mar 14.
4
Impact of Periprocedural Adverse Events After PCI and CABG on 5-Year Mortality: The EXCEL Trial.经皮冠状动脉介入治疗(PCI)和冠状动脉旁路移植术(CABG)后围手术期不良事件对 5 年死亡率的影响:EXCEL 试验。
JACC Cardiovasc Interv. 2023 Feb 13;16(3):303-313. doi: 10.1016/j.jcin.2022.10.011.
5
Stents versus bypass surgery: 3-year mortality risk of patients with coronary interventions aged 50+ in Germany.支架与旁路手术:德国 50 岁以上接受冠状动脉介入治疗患者的 3 年死亡率风险。
J Cardiothorac Surg. 2022 Oct 1;17(1):246. doi: 10.1186/s13019-022-02014-2.
6
Machine learning algorithms for predicting mortality after coronary artery bypass grafting.用于预测冠状动脉搭桥术后死亡率的机器学习算法
Front Cardiovasc Med. 2022 Aug 24;9:977747. doi: 10.3389/fcvm.2022.977747. eCollection 2022.
7
Repeat Revascularization Post Coronary Artery Bypass Grafting: Comparing Minimally Invasive and Traditional Sternotomy Techniques in 1468 Cases.冠状动脉旁路移植术后再次血运重建:1468例微创与传统胸骨切开术技术比较
Cureus. 2022 Jun 6;14(6):e25687. doi: 10.7759/cureus.25687. eCollection 2022 Jun.
8
Drug-eluting stents for the treatment of coronary artery disease: A review of recent advances.药物洗脱支架治疗冠状动脉疾病:最新进展综述。
Expert Opin Drug Deliv. 2022 Mar;19(3):269-280. doi: 10.1080/17425247.2022.2044784. Epub 2022 Feb 22.
9
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2021年美国心脏病学会/美国心脏协会/心血管造影和介入学会冠状动脉血运重建指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2022 Jan 18;145(3):e18-e114. doi: 10.1161/CIR.0000000000001038. Epub 2021 Dec 9.
10
Drug-eluting stent thrombosis: current and future perspectives.药物洗脱支架血栓形成:当前和未来的观点。
Cardiovasc Interv Ther. 2021 Apr;36(2):158-168. doi: 10.1007/s12928-021-00754-x. Epub 2021 Jan 13.